The traditional model for biomedical discovery funded by a single government agency or foundation has served us well for many decades but it is not equipped to address the big global challenges we face.
While artificial intelligence has been developed for some time, it was the remarkable breakthrough and the availability to mass usage that has aroused the interests of many people, including individuals, industries and government entities.
Mitochondrial dysfunction is seen in many common and rare diseases, but given their central role in cell homeostasis, it remains puzzling why this targets some cell-types and not others.
The computational techniques of atomistic simulation and machine learning (ML) offer an avenue to rapidly invent new materials which is vital for addressing pressing societal challenges in health, energy and sustainability.
Recent advances in biotechnology coupled with a rapidly increasing understanding of the fundamental genetic causes of disease are not only identifying those at risk of disease but also revealing new drug targets.
Recent advances in epigenetics and epigenomics have a tremendous impact on our understanding of biological phenomena and have galvanized the research of complex diseases, notably cancer.
The discovery of the so-called High Temperature Superconductors in 1987, which in bulk forms are able to conduct very high electrical currents and hence generate extremely high magnetic fields at liquid nitrogen temperatures, was heralded as the most significant scientific breakt Tough since the…
Join our guest speaker, Professor Ken Smith from the University of Cambridge as he uncovers the subject of "The Jeffrey Cheah Biomedical Centre and the Cambridge rapid response to the SARS-CoV-2 pandemic" and gain a deeper understanding on immune responses to virus infection and vaccination.